Kate Hill

Company Secretary at Kazia Therapeutics

Ms Kate Hill has over 20 years’ experience as an audit partner with Deloitte Touche Tohmatsu, working with ASX listed and privately owned clients. She has worked extensively in regulated environments including assisting with Initial Public Offerings, capital raising and general compliance, as well as operating in an audit environment.

In addition to her role at Kazia, Kate is a Non-Executive Director and Chair of the Audit Committee of CountPlus Limited (ASX:CUP) and Elmo Software Limited (ASX:ELO). She is independent Chair of Seeing Machines Limited (AIM:SEE), as well as being a member of other Committees of those boards.

Ms Hill is a member of the Institute of Chartered Accountants in Australia and New Zealand, and a graduate of the Australian Institute of Company Directors.


Org chart

This person is not in the org chart


Teams

This person is not in any teams


Offices

This person is not in any offices


Kazia Therapeutics

3 followers

Kazia Therapeutics is an oncology-focused biotechnology company, developing innovative anti-cancer drugs. Headquartered in Sydney, Australia, Kazia Therapeutics collaborates with leading scientists, clinicians, and investors around the world.


Industries

Headquarters

Sydney, Australia

Employees

11-50

Links